top of page

Jazz Pharmaceuticals making serious moves



Jazz Pharmaceuticals, a major global pharmaceutical company, is making a serious move into the cannabis industry proposing to buy GW Pharmaceuticals for $7.2 Billion, a premium price of about 50% over GW’s closing price on Tuesday.


Jazz, which has its corporate headquarters in Dublin, Ireland, and an office in Philadelphia, had a market value of $8.7 billion as of the close of trading Tuesday.


Read more here:




10 views0 comments

Comments


bottom of page